MNI: Patient Education Role Playing

In these videos, the faculty members illustrate how they talk with patients about melanoma therapies, with an emphasis on overall education as well as side-effect management. From these experts, you may garner communication pearls that are helpful as you develop or refine your educational strategy related to new advances in melanoma.

These videos are for your educational purposes only at this point (ie, please do not share the link to these video with patients). Soon, we will make these videos available for patients to access directly through AIM at Melanoma.

In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, discusses key immune-related adverse events (irAEs) associated with immune checkpoint inhibitors, with a focus on considerations in the adjuvant setting.

In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, discusses steps patients can take to deal with the skin toxicities associated with use of immune checkpoint inhibitors.

In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, talks about the workup of confusion in patients receiving immune checkpoint inhibitors.

In this video, Eric D. Whitman, MD, FACS, of the Atlantic Health System, discusses immune-related adverse events associated with immune checkpoint inhibitors.

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the financial considerations patients should to be aware of before starting adjuvant therapy for melanoma.

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the issues patients should be aware of regarding pregnancy prevention and future fertility before starting adjuvant therapy for melanoma.

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, provides a helpful list of questions patients can ask their provider about adjuvant therapy after having surgery for melanoma.